<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Helwick, Caroline</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Verheugt, Freek W.A.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">New Directions in Antithrombotic Therapy</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2007</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2007-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">34-35</style></pages><abstract><style  face="normal" font="default" size="100%">This article discusses strategies for long-term antithrombotic therapy, ways to balance the risks and benefits of antithrombotic therapy, as well as gives an overview of evidence supporting the use of long-term antithrombotic therapy after acute coronary syndrome, and suggests strategies for balancing the benefits and risks of long-term antithrombotic therapy for patients with NSTEMI or STEMI.</style></abstract><number><style face="normal" font="default" size="100%">7</style></number><volume><style face="normal" font="default" size="100%">7</style></volume></record></records></xml>